Volume 127, Issue 10 pp. 2239-2241
General Otolaryngology

Successful ablation of plunging ranula by ultrasound-guided percutaneous ethanol injection

Michelle-Linh T. Nguyen BA

Michelle-Linh T. Nguyen BA

Department of Otolaryngology, Stanford University School of Medicine, Stanford, California, U.S.A.

Search for more papers by this author
Lisa A. Orloff MD, FACS, FACE

Corresponding Author

Lisa A. Orloff MD, FACS, FACE

Department of Otolaryngology, Stanford University School of Medicine, Stanford, California, U.S.A.

Send correspondence to Lisa A. Orloff, M.D., Stanford Cancer Center, 875 Blake Wilbur Drive, CC-2225, Stanford, CA, 94305. E-mail: [email protected]Search for more papers by this author
First published: 13 April 2017
Citations: 9

Presented as an oral presentation at the Triological Society Combined Sections Meeting, New Orleans, Louisiana, U.S.A., January 21, 2017.

Financial Disclosure: The authors have no funding, financial relationships, or conflicts of interest to disclose.

Abstract

Evidence supporting any one treatment for plunging ranula is limited. Standard treatment—complete excision of the sublingual gland and ranula—is invasive and morbid given the close operative proximity to the submandibular duct and lingual nerve. OK-432 (Picibanil; Chugai Pharmaceutical Co., Tokyo, Japan) sclerotherapy has been studied as a less invasive treatment but is inaccessible in the United States. This report illustrates the successful management of a plunging ranula using ultrasound-guided percutaneous ethanol injection. Within 2 months of the procedure, the patient had complete resolution of the plunging ranula, with no associated side effects. We propose that ultrasound-guided percutaneous ethanol injection be considered for the management of plunging ranula. Laryngoscope, 127:2239–2241, 2017

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.